Three major hepatitis B virus (HBV) antigens include HBcAg, HBeAg and HBsAg. HBeAg is the extracellular form of HBcAg, and is seen almost exclusively in people who have circulating serum HBV DNA. Presence of HBsAg in serum indicates that the individual has contracted HBV infection. Chronic hepatitis HBeAg-negative/anti-HBe-positive is known as an important form of chronic hepatitis B in the Mediterranean region. In this report, we used Real-Time PCR and ELISA for detection of HBV and HBeAg/HbsAg, respectively. In our investigation on 4243 HBV cases referred to the Mahdieh Clinical Laboratory between 2008 and 2016, we found a 53-year-old man with clinical symptoms of hepatitis and abnormal molecular and serological features. Despite the presence of clinical symptoms and high viral load (128 × 10 5 iu/ml), the patient was HBsAg-positive and HBeAg-negative. Identifying this type of HBV could indicate spread of this type of hepatitis in Isfahan, Iran.
A mutation in the HBV precore region (G to A conversion at position 1896) leads to inhibition of HbeAg production. Moreover, the levels of viral replication, viral genotype and probably the genetic variability of the virus influence the expression of viral antigens [4] [5] [6] . In the early 1980s, a mutant form of CHB was reported with replication ability and negative HBeAg [7] [8] [9] . We hereby report for the first time, a case with anti-HBe-positive but HBeAg-negative CHB infection in Isfahan, Iran.
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INTRODUCTION
Hepatitis B virus (HBV) is a doublestranded DNA virus from the Hepadnavirus family [1] . Approximately 350 to 400 million people worldwide are infected with the virus [2] . There are three major HBV antigens including hepatitis B surface antigen (HBsAg), hepatitis B core antigen (HBcAg) and hepatitis B envelope antigen (HBeAg), each of which is of clinical importance in diagnostic tests (Table 1) . HBcAg surrounds the viral genome and its expression on the surface of hepatocytes induces an immune response for elimination of infected cells. HBeAg is the extracellular form of HBcAg, and is a viral replication marker similar to HBcAg. HBeAg is found almost exclusively in people who have circulating serum HBV DNA. Elevated level of HBsAg can be detected in serum of patients during acute and chronic phases of HBV infection. Therefore, the presence of HBsAg in serum indicates that the individual is infected (3). Individuals exposed to HBV generally fall into three phases: immune tolerant phase, chronic hepatitis B phase (CHB), and inactive hepatitis B (or asymptomatic hepatitis B) carrier phase (2) . Immune tolerant phase is characterized by presence of HBeAg and high levels of HBV DNA in serum, but minimal or no inflammation on liver biopsy. CHB phase is characterized by high levels of HBV DNA (>105 copies/mL), presence of HBeAg or antiHBe and chronic inflammation on liver biopsy. Inactive hepatitis B carrier phase is characterized by presence of anti-HBe with HBV DNA levels but not as high as in chronic hepatitis B (2). 
CONCLUSIONS
Considering the detection of this case in Isfahan, it seems that the prevalence of this type of hepatitis in Isfahan is increasing. Therefore, it is highly recommended to provide a comprehensive plan to prevent the spread of this type of hepatitis.
